Table 1 Baseline characteristics of the study population
From: Interferon-gamma release assay for screening of tuberculosis infection in children
Characteristic | X.DOT-TB (N = 15,129) n(%) | QFT-GIT (N = 18,533) n(%) | Total (N = 33,662) n(%) |
|---|---|---|---|
Gender | |||
M | 8394(55.5) | 10,485(56.6) | 18,879(56.1) |
F | 6735(44.5) | 8048(43.4) | 14,783(43.9) |
Age group, y | 7.0 ± 4.5 | 7.4 ± 4.2 | 7.2 ± 4.3 |
0–4 | 5080(33.6) | 6039(32.6) | 11,119(33) |
5–9 | 5109(33.8) | 6419(34.6) | 11,528(34.2) |
10–14 | 4314(28.5) | 5385(29.1) | 9699(28.8) |
15–19 | 626(4.1) | 690(3.7) | 1316(3.9) |
Diseases Classification | |||
Respiratory | 4459(24.0) | 2863(12.5) | 7322(17.6) |
Central nervous | 781(4.2) | 965(4.2) | 1746(4.2) |
Urinary | 1116(6.0) | 2064(9.0) | 3180(7.7) |
Digestive | 1670(9.0) | 3096(13.5) | 4766(11.5) |
Hematological and neoplastic | 1558(8.4) | 3734(16.2) | 5292(12.7) |
Rheumatic immune | 4433(23.9) | 4103(17.8) | 8536(20.5) |
Cardiovascular | 1119(6.0) | 1904(8.3) | 3023(7.3) |
Other | 3421(18.4) | 4263(18.5) | 7684(18.5) |